Discovery of 1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid as a First-in-Class Low-Cytotoxic Nanomolar Metallo β-Lactamase Inhibitor.

Citation data:

ChemMedChem, ISSN: 1860-7187, Vol: 12, Issue: 11, Page: 845-849

Publication Year:
2017
Usage 3
Abstract Views 3
Captures 9
Readers 9
Social Media 5
Tweets 5
Citations 1
Citation Indexes 1
PMID:
28482143
DOI:
10.1002/cmdc.201700182
Author(s):
Shin, Woo Shik; Bergstrom, Alexander; Bonomo, Robert A; Crowder, Michael W; Muthyala, Ramaiah; Sham, Yuk Yin
Publisher(s):
Wiley-Blackwell
Tags:
Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics; Chemistry
Most Recent Tweet View All Tweets
article description
VIM-2 is one of the most common carbapenem-hydrolyzing metallo β-lactamases (MBL) found in many drug-resistant Gram-negative bacterial strains. Currently, there is a lack of effective lead compounds with optimal therapeutic potential within our drug development pipeline. Here we report the discovery of 1-hydroxypyridine-2(1H)-thione-6-carboxylic acid (3) as a first-in-class metallo β-lactamase inhibitor (MBLi) with a potent inhibition K of 13 nm against VIM-2 that corresponds to a remarkable 0.99 ligand efficiency. We further established that 3 can restore the antibiotic activity of amoxicillin against VIM-2-producing E. coli in a whole cell assay with an EC of 110 nm. The potential mode of binding of 3 from molecular modeling provided structural insights that could corroborate the observed changes in the biochemical activities. Finally, 3 possesses a low cytotoxicity (CC ) of 97 μm with a corresponding therapeutic index of 880, making it a promising lead candidate for further optimization in combination antibacterial therapy.